AVIXAA Poly-Peptide Cellular Meso Solution is an ultra-pure, multi-target cellular biostimulant formulated for in-clinic intradermal delivery via micro-needling, meso-infusion, or electroporation platforms. Designed to replenish depleted cellular micro-environments, it provides the precise biochemical building blocks required for rapid neocollagenesis, elastogenesis, and intercellular matrix repair.
Each sterile pyrogen-free vial contains an evidence-based formulation of 24 essential amino acids, 12 vitamins, 8 minerals, 6 coenzymes, and 4 biomimetic signaling oligopeptides synergized with non-crosslinked pharmaceutical hyaluronic acid for sustained cellular nourishment.
Biochemical Architecture & Active Profile
Engineered with high thermodynamic stability and optimal osmotic balance to ensure maximum cellular bio-absorption without tissue trauma:
- Biomimetic Peptide Complex (Copper Tripeptide-1, sh-Oligopeptide-1, sh-Polypeptide-2): Triggers fibroblast activation and accelerates endogenous collagen type I and III synthesis.
- Essential Dermal Amino Acids: Glycine, L-Proline, L-Lysine, and Hydroxyproline supplying rate-limiting substrates for triple-helix collagen assembly.
- Cellular Coenzymes & Micronutrients: Coenzyme A, NAD, and Vitamin B-Complex restoring cellular ATP production and redox homeostasis.
- Non-Crosslinked Hyaluronic Acid: High-purity linear HA providing immediate viscoelastic dermal hydration and active nutrient carriage.
Strictly manufactured in pharmaceutical ISO 13485 sterile cleanroom suites with rigorous pyrogen testing, ensuring flawless tolerance across all Fitzpatrick skin phototypes.
Physician Protocol & In-Clinic Integration
Recommended application protocols for licensed aesthetic clinicians:
Targeted Micro-Infusion
0.5mm - 1.5mm needle depth using AVIXAA Precision Dermal Platform. Recommended dose: 2.5ml to 5.0ml per facial zone.
Treatment Frequency
Initial loading phase: 3 sessions spaced 14 days apart. Maintenance: 1 session every 8-12 weeks for long-term dermal ECM health.
